Recurrent and metastatic squamous cell carcinoma in lung transplant recipient on voriconazole: Lessons learned

Documenti analoghi

• High Cumulative Dose Exposure to Voriconazole is Associated with Cutaneous Squamous Cell Carcinoma in Lung Transplant Recipients
  di: Singer, Jonathan P., et al.
  Pubblicazione: (2012)
• Catastrophic Squamous Cell Carcinoma in Lung Transplant Patients Treated with Voriconazole
  di: Ibrahim, Sherrif F., et al.
  Pubblicazione: (2010)
• Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients
  di: Mansh, M., et al.
  Pubblicazione: (2015)
• Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States
  di: D’Arcy, Monica E., et al.
  Pubblicazione: (2020)
• Metastatic squamous cell carcinoma in a bone marrow transplant recipient
  di: Chetan Mittal, et al.
  Pubblicazione: (2013-03-01)